Featured Research

from universities, journals, and other organizations

Inflammation research opens route to better pain relief

Date:
March 26, 2010
Source:
University of Leeds
Summary:
Scientists have discovered how two proteins play a key role in the way we feel pain, offering new targets on which drug development can be focused.

Research at the University of Leeds could pave the way to a new generation of painkillers by providing a new theory of how inflammation causes pain.

An international group of scientists led by Dr Nikita Gamper of the University's Faculty of Biological Sciences has discovered how two proteins play a key role in the way we feel pain, offering new targets on which drug development can be focused. The findings are published online March 24 in the Journal of Clinical Investigation.

"Pain originates from a series of electrical signals sent by nerve cells in outlying areas of the body to the central nervous system and ultimately the brain," said Dr Gamper. "We still know very little about the mechanism by which these signals are generated, so existing painkillers are non-specific, designed to generally dull the reception of the signals in the central nervous system.

"Because they target the central nervous system, some stronger pain killers can provoke severe side effects, such as disorientation, drowsiness or nausea -- and many of these drugs are addictive. Our research is trying to better understand where pain originates, to enable more targeted drugs to be developed that avoid these side effects."

Pain can be a healthy response, informing us that something in our bodies is going wrong, is damaged or at risk of being damaged. Inflammation often distorts this healthy reaction, causing pain that lasts much longer than is needed to transmit the message, as is the case in toothache, sore throat or arthritis.

In research funded jointly by the Wellcome Trust and the Medical Research Council, Dr Gamper's team has discovered that a substance released at sites of inflammation -- called bradykinin -- manipulates two proteins commonly found at the damage-sensing terminals of peripheral nerve cells. When targeted by the bradykinin, these proteins then cause the nerve cells to send electrical 'pain' signals to the brain.

The research offers a new concept of how inflammation can cause pain and is the first time that one of these proteins -- Calcium-activated chloride channel Ano1 -- has been shown to have a role in pain transmission. The other protein, called M-type potassium channel, although previously linked to neuronal activity, was not known to have a role in inflammatory pain.

"The process we've identified takes place in the peripheral sensing neurons where the pain signal is generated," said Dr Gamper. "Targeting the peripheral nervous system for drug development would create painkillers that would leave the central nervous system untouched, thus reducing the likelihood of side effects."

Dr Gamper is now planning to study these proteins in more depth and identify their possible role in other types of pain, such as neuropathic pain and migraine.


Story Source:

The above story is based on materials provided by University of Leeds. Note: Materials may be edited for content and length.


Cite This Page:

University of Leeds. "Inflammation research opens route to better pain relief." ScienceDaily. ScienceDaily, 26 March 2010. <www.sciencedaily.com/releases/2010/03/100324174045.htm>.
University of Leeds. (2010, March 26). Inflammation research opens route to better pain relief. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/03/100324174045.htm
University of Leeds. "Inflammation research opens route to better pain relief." ScienceDaily. www.sciencedaily.com/releases/2010/03/100324174045.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins